Cara Therapeutics | CARA - DETTE

Prix De L'Action
3.17
Variation Quotidienne
-0.16 -4.80%
Mensuellement
-19.95%
Annuel
-79.48%
Q1 Prévisions
3.19




DETTE Changement Date
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Assertio Holdings USD 38.87M 615K 2023-09
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Chugai Pharma JPY 14.11B 1.93B 2022-12
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
J&J USD 45.8B 4.97B 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Pacira USD 372.19M 4.53M 2025-12
Pfizer USD 60.85B 78M 2025-09
RedHill Biopharma USD 214K 142K 2025-06
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12